NWBO

Northwest Biotherapeutics, Inc. News Headlines

$6.63
*  
0.29
4.57%
Get NWBO Alerts
*Delayed - data as of Jul. 29, 2014  -  Find a broker to begin trading NWBO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NWBO Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Northwest Bio And The Curious Relationship With Cognate BioServices
7/17/2014 6:55:00 PM - Seeking Alpha

Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Promotion Scheme
7/17/2014 8:25:00 AM - Seeking Alpha

Why Immunotherapies Have Made DelMar's Lead Drug A Necessity In Brain Cancer
7/15/2014 2:40:00 PM - Seeking Alpha

Behind The Promotion Of Northwest Bio
7/7/2014 10:46:00 AM - Seeking Alpha

Behind The Promotion Of Northwest Bio
7/7/2014 9:35:29 AM - SeekingAlpha

Behind The Promotion Of Northwest Bio
7/7/2014 9:35:00 AM - Seeking Alpha

Placing Northwest Biotherapeutics In The Figure-4 Deadfall Trap
6/26/2014 11:22:00 AM - Seeking Alpha

Long Or Short: Cancer Cures
6/26/2014 10:12:00 AM - Seeking Alpha

Long Or Short - Cancer Cures
6/24/2014 3:06:00 AM - Seeking Alpha

Northwest Biotherapeutics Gets Called Out: Should Investors Worry?
6/23/2014 11:54:00 AM - Seeking Alpha

The War Of Words: Balancing Perspectives On Northwest Bio's DCVax-Direct
6/20/2014 3:27:00 PM - Seeking Alpha

Sector Update: Healthcare Stocks Mixed in Afternoon Trade; Northwest Biotherapeutics Rallies on DCVax Trial Results
6/11/2014 1:43:37 PM - MT Newswires

Sector Update: Healthcare
6/11/2014 1:17:26 PM - MT Newswires

Northwest Bio Initiates Phase III DCVax-L Trial In Germany - Quick Facts
6/10/2014 8:28:00 AM - RTT News

The Case Of Northwest Biotherapeutics' Missing DMC Recommendation
6/4/2014 12:25:00 PM - Seeking Alpha

Northwest Biotherapeutics: Academic Results Create Positive Risk/Reward
6/2/2014 3:05:00 PM - Seeking Alpha

Celldex: The Race Leader In Glioblastoma Multiforme
5/29/2014 3:17:00 PM - Seeking Alpha

Cramer's Lightning Round - Don't Hurt Yourself With Abercrombie & Fitch (5/28/14)
5/29/2014 6:21:00 AM - Seeking Alpha

Northwest Biotherapeutics: Management Discusses Interim Data On Phase I/II Trial Of DCVax-Direct
5/28/2014 5:13:00 PM - Seeking Alpha

Northwest Biotherapeutics Reports On Sarcoma Patient Treated With DCVAx-Direct
5/15/2014 10:43:00 AM - Seeking Alpha

Refuting The Latest Negative Blog On Northwest Biotherapeutics
4/3/2014 3:50:00 PM - Seeking Alpha

Analysis: Northwest Biotherapeutics DCVax-L Germany Approval Under Hospital Exemption Early Access Program
3/11/2014 9:30:00 AM - Seeking Alpha

Analysis: Northwest Biotherapeutics DCVax-L Germany Approval Under Hospital Exemption Early Access Program
3/11/2014 8:59:57 AM - SeekingAlpha

Analysis: Northwest Biotherapeutics DCVax-L Germany Approval Under Hospital Exemption Early Access Program
3/11/2014 8:59:00 AM - Seeking Alpha

Healthcare Stocks Mixed in Afternoon Trade; Northwest Biometrics Jumps 13% After German Regulators OK Cancer Drug
3/10/2014 1:04:34 PM - MT Newswires